Disc Medicine, Inc.
IRON
$-0.22
Change (1 day)
$77.60
Year High
$25.60
Year Low
Categories
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Disc Medicine, Inc. (IRON) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | -358,281,000 | 22.88 M | 368 M | 365.66 M | |
| 2022 | -193,277,000 | 23.61 M | 200.21 M | 198.49 M | |
| 2021 | -86,383,000 | 156.61 M | 92.41 M | 90.48 M | |
| 2020 | 20.43 M | 4.82 M | 122.09 M | 1.34 M |